Lannett Company Inc secures FDA approval for Hydromorphone Hydrochloride Tablets

Submit press release

Existing customer?
Log in

New customer?
Sign up

Latest Headlines
Motorola Mobility Notifies Certain Purchasers of Refurbished Motorola...
DNR Commemorates Conservation Officer's Death, Honors His...
Campaign tackles domestic violence ahead of Six Nations...
Justice Department Announces Luke J...
City of Lansing's River Trail closed at the M-43/Saginaw Street...
Michigan Liquor Control Commission Offers Tips on How to Host a...

M2 Archive: Preview

You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.

Lannett Company Inc secures FDA approval for Hydromorphone Hydrochloride Tablets
Generic pharmaceutical products provider Lannett Company Inc (NYSE AMEX:LCI) declared on Thursday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg.
The...

If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search